Sally Kohn: I remember my father was dying and I went and visited him many times in the hospital. Turns out he had SARS. He may have had COVID. But to go visit him in the hospital at that time, he had any other things wrong. The SARS just was like a side thing. And we were using masks very cavalierly, meaning, yeah, I put a new one on to try this one. You know, put another one on and it would break. She says there was zero discussion of any kind of market process that might help with this.
When there's no vaccine on the market, people will look for other ways to be safe, including school closures and the handwashing of groceries. Listen as economist Casey Mulligan of the University Chicago talks with EconTalk's Russ Roberts about the costs of delaying a vaccine, the hidden costs of FDA regulation, and what we learned and failed to learn about the Covid pandemic.